• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Harrison.ai Secures $112M to Expand AI-Powered Medical Diagnostics

by Fred Pennic 02/11/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Harrison.ai, a global healthtech company, today announced the completion of a $112M in Series C funding round co-led by Aware Super, ECP, and existing investor Horizons Ventures. New investors, including Australia’s National Reconstruction Fund Corporation (NRFC), Ord Minnett, and Wollemi Capital Group, also participated, along with existing investors Blackbird Ventures and Alpha JWC Ventures. This brings Harrison.ai’s total capital raised to date to over $240M.

– The investment will fuel the company’s expansion into the United States, fuel its product roadmap, and continue its growth in the UK, EMEA, and APAC regions.  

Advanced AI Solutions for Cancer Detection and Other Critical Illnesses

Harrison.ai’s technology leverages AI to analyze medical images, such as CT scans and X-rays, to assist clinicians in detecting signs of cancer and other critical illnesses earlier and more accurately. This technology has the potential to revolutionize healthcare by improving diagnostic accuracy, reducing treatment delays, and saving lives.

Harrison.ai aims to address the growing demand for equitable and effective healthcare by addressing two key challenges:

  • Shortage of skilled clinicians: The global shortage of radiologists and pathologists is a significant barrier to timely and accurate diagnosis. Harrison.ai’s technology can help alleviate this burden by augmenting human capabilities.  
  • Disparities in access to care: Many regions, both developed and underdeveloped, lack access to advanced diagnostic services. Harrison.ai’s solutions can help bridge this gap by providing remote access to diagnostic expertise.  

Early Detection and Improved Outcomes

Harrison.ai’s technology has demonstrated significant potential for early detection and improved clinical outcomes. Studies have shown that Harrison.ai’s AI for chest radiography can aid in the early detection of lung cancer, with over 32% of cases being diagnosed sooner than conventional methods. This early detection can lead to more effective treatment options and improved patient outcomes.

Global Expansion and Partnerships

Harrison.ai is establishing a North American presence in Boston to support its growth in the United States. The company has already received 12 FDA clearances and one of its CT Brain algorithms has FDA Breakthrough Device Designation and Medicare reimbursement through the New Technology Add-on Payment (NTAP).

Harrison.ai has also formed partnerships with leading healthcare institutions and organizations worldwide. For example, it has been selected by the Danish public healthcare system to help clinicians deliver better outcomes and is powering all CT Brain scans across public accident and emergency (A&E) systems in Hong Kong

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |